Abstract |
Overexpression of the MT1 melatonin receptor in MCF-7 human breast cancer cells significantly enhances the response of these cells to the growth-inhibitory actions of melatonin. Athymic nude mice implanted with MT1-overexpressing MCF-7 cells developed significantly fewer palpable tumors (60% reduction) compared to mice receiving vector-transfected MCF-7 cells (vt-MCF-7). In response to exogenous melatonin, tumor incidence in the mice receiving the MT1-overexpressing MCF-7 cells was decreased by 80% compared to mice receiving vt-MCF-7 cells. Interestingly, daily melatonin administration did not decrease tumor incidence in mice receiving vt-MCF-7 cells, but rather stimulated overall tumor formation.
|
Authors | A Collins, L Yuan, T L Kiefer, Q Cheng, L Lai, S M Hill |
Journal | Cancer letters
(Cancer Lett)
Vol. 189
Issue 1
Pg. 49-57
(Jan 10 2003)
ISSN: 0304-3835 [Print] Ireland |
PMID | 12445677
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Receptors, Cell Surface
- Receptors, Cytoplasmic and Nuclear
- Receptors, Melatonin
- Melatonin
|
Topics |
- Animals
- Breast Neoplasms
(prevention & control)
- Female
- Humans
- Melatonin
(pharmacology)
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Receptors, Cell Surface
(genetics, metabolism, physiology)
- Receptors, Cytoplasmic and Nuclear
(genetics, metabolism, physiology)
- Receptors, Melatonin
- Transfection
- Transplantation, Heterologous
- Tumor Cells, Cultured
|